Company Profile
Olema Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- OLMA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Olema Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
10.53 USD (+5.30%)
Close
Last updated: June 23, 2026 at 00:00
919.77M USD
Market cap
Why the stock is moving
OLMA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Olema Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Olema Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Olema Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Olema Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
Source: Olema Pharmaceuticals, Inc.
- 03
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
Source: Olema Pharmaceuticals, Inc.
- 04
Olema Oncology to Participate in Upcoming Investor Conferences
Source: Olema Pharmaceuticals, Inc.
- 05
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Source: Olema Pharmaceuticals, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Olema Pharmaceuticals, Inc. (OLMA)?
Olema Pharmaceuticals, Inc. (OLMA) most recently closed at 10.53 USD, a +5.30% move versus the previous session.
What is the market cap of Olema Pharmaceuticals, Inc. (OLMA)?
Olema Pharmaceuticals, Inc. currently has a market capitalization of 919.77M USD on BioPharmSignal.
What does Olema Pharmaceuticals, Inc. do?
Olema Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is OLMA stock listed?
Olema Pharmaceuticals, Inc. (OLMA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Olema Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Olema?
Olema Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Olema Pharmaceuticals, Inc. targeting with Olema?
Olema Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Olema Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.